Toxoplasma chorioretinitis
ICD-10 B58.3 is a billable code used to indicate a diagnosis of toxoplasma chorioretinitis.
Toxoplasma chorioretinitis is an ocular manifestation of Toxoplasma gondii infection, a protozoan parasite that can cause significant morbidity, particularly in immunocompromised individuals and during pregnancy. The condition is characterized by inflammation of the choroid and retina, leading to symptoms such as blurred vision, floaters, and in severe cases, vision loss. The infection is often acquired through ingestion of oocysts found in contaminated food or water, or through contact with infected cat feces. In immunocompetent individuals, Toxoplasma chorioretinitis may remain asymptomatic or present with mild symptoms, but in those with weakened immune systems, such as HIV/AIDS patients or organ transplant recipients, it can lead to severe ocular complications. Diagnosis is typically made through clinical examination, supported by serological tests for Toxoplasma antibodies and imaging studies such as fundus photography or OCT. Treatment usually involves a combination of pyrimethamine and sulfadiazine, along with folinic acid to mitigate the side effects of pyrimethamine. Early diagnosis and treatment are crucial to prevent irreversible damage to the retina and preserve vision.
Detailed ocular examination findings, including visual acuity and fundoscopic findings.
Patients presenting with sudden vision changes, floaters, or a history of immunosuppression.
Ensure documentation reflects the severity of the condition and any associated systemic symptoms.
Comprehensive patient history, including risk factors for Toxoplasma infection and results of serological tests.
Immunocompromised patients with ocular symptoms or pregnant women with potential exposure.
Document any co-infections and the rationale for treatment choices.
Used when a patient presents with symptoms suggestive of chorioretinitis.
Document visual acuity, fundoscopic findings, and any relevant history.
Ophthalmologists should ensure comprehensive documentation to support the diagnosis.
Common symptoms include blurred vision, floaters, and in severe cases, vision loss. Patients may also experience eye pain or redness.
Diagnosis is made through clinical examination, serological testing for Toxoplasma antibodies, and imaging studies such as fundus photography.
Treatment typically involves a combination of pyrimethamine and sulfadiazine, along with folinic acid to prevent side effects.
